G. Kelly Martin - 21 Feb 2022 Form 4 Insider Report for Radius Health, Inc.

Role
CEO and President, Director
Signature
/s/ G. Kelly Martin
Issuer symbol
N/A
Transactions as of
21 Feb 2022
Net transactions value
$0
Form type
4
Filing time
25 Feb 2022, 15:30:30 UTC
Next filing
15 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RDUS Common Stock Award $0 +75,000 $0.000000 75,000 21 Feb 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units awarded under the 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of RDUS common stock. The restricted stock units vest in three equal annual installments on each of the first three anniversaries of the grant date of February 21, 2022, subject to continued service with RDUS through such dates.